Actinium Pharmaceuticals (ATNM) Ending Cash Balance (2009 - 2026)
Actinium Pharmaceuticals' Ending Cash Balance was $76.99 million in Q4 2023, down 29.8% from $109.61 million a year earlier.
Powered by 
Analysis
Actinium Pharmaceuticals (ATNM) Ending Cash Balance (2009 - 2026) Analysis & Trends
From Q3 2010 onward, Actinium Pharmaceuticals has reported Ending Cash Balance for 50 quarters.
- Ending Cash Balance shows a five-year compound annual growth rate of 40.4% (FY2018 to FY2023).
- In earlier years, Ending Cash Balance was $109.61 million in FY2022 (+40.1%), $78.22 million in FY2021 (+22.2%), $64 million in FY2020 (+560.3%) and $9.69 million in FY2019 (-31.3%).
- The Q4 2023 figure marks the lowest quarterly Ending Cash Balance since Q1 2022.
- Compared with a year earlier, Ending Cash Balance was higher in four of the last seven quarters, with growth averaging 14.0%.
- The best year-over-year quarter for Ending Cash Balance over five years was Q4 2020 (growth of 560.3%); the worst was Q1 2019 (a decline of 61.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Actinium Pharmaceuticals | 49.05 Mn | -130.95 Mn | - | 48.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 48.33 Mn |
| Mar 31, 2026 | 48.33 Mn |
| Dec 31, 2025 | 73.23 Mn |
| Sep 30, 2025 | 73.23 Mn |
| Jun 30, 2025 | 73.23 Mn |
| Mar 31, 2025 | 73.23 Mn |
| Dec 31, 2024 | 76.99 Mn |
| Sep 30, 2024 | 76.99 Mn |
| Jun 30, 2024 | 76.99 Mn |
| Mar 31, 2024 | 76.99 Mn |
| Dec 31, 2023 | 76.99 Mn |
| Sep 30, 2023 | 109.61 Mn |
| Jun 30, 2023 | 91.58 Mn |
| Mar 31, 2023 | 95.23 Mn |
| Dec 31, 2022 | 109.61 Mn |
| Sep 30, 2022 | 112.51 Mn |
| Jun 30, 2022 | 116.72 Mn |
| Mar 31, 2022 | 72.41 Mn |
| Dec 31, 2021 | 78.22 Mn |
| Sep 30, 2021 | 82.47 Mn |
API Access
Actinium Pharmaceuticals Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=ATNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "ATNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=ATNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();